查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全基因組測序市場規模、份額和趨勢分析報告，按產品（儀器、耗材、服務）、類型、工作流程、應用、最終用途、地區、細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1233234

全基因組測序市場規模、份額和趨勢分析報告，按產品（儀器、耗材、服務）、類型、工作流程、應用、最終用途、地區、細分市場預測，2023-2030 年

Whole Genome Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Services), By Type, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

全基因組測序市場增長和趨勢

Grand View Research, Inc. 的一份新報告顯示，從 2023 年到 2030 年，全球全基因組測序市場規模將以 20.06% 的複合年增長率增長，到 2030 年將達到 66.7 億美元。

這一市場增長的推動因素是全基因組測序在基因組作圖計劃中的日益普及以及遺傳病（包括罕見遺傳病）患病率的上升。您可以 2021 年 11 月發表在《新英格蘭醫學雜誌》上的一項研究報告稱，全基因組測序將使多種罕見疾病的早期診斷成為可能，從而導致向精準醫學的轉變。

此外，增加對使用 WGS 早期檢測和治療疾病的研發投資也有望推動市場增長。 例如，2023 年 2 月，印度尼西亞政府和基因組科學計劃從全球基金獲得了 3000 萬美元的投資，用於早期檢測和診斷 COVID-19、結核病、癌症、遺傳病、腦部疾病等疾病, 代謝紊亂. 建立了實施治療方法的設施網絡。

全基因組測序具有廣泛的應用，隨著政府機構採用這些技術解碼人類、植物、動物和微生物基因組，預計將推動市場增長。我來了。 例如，美國食品和藥物管理局（FDA）在各國食源性疾病暴發期間就採用這種方法來鑑定食源性病原體。 自 2008 年以來，FDA 在其全基因組測序 (WGS) 計劃下採用了這項技術，因為它可以比脈衝場凝膠電泳 (PFGE) 更有效地識別所有食源性病原體菌株。

隨著技術的進步，創新的全基因組測序產品相繼推出，可為各種疾病和感染提供經濟實惠、準確且及時的診斷。 這有助於市場增長。 例如，2022 年 12 月，LifeCell International Pvt. Ltd. 與 Haystack Analytics 合作推出了全基因組測序測試“TB”，以確定結核病感染的診斷信息並應對耐藥性挑戰。

COVID-19 大流行增加了全球對該技術的需求，從而能夠快速識別 SARS-CoV-2 並開發可能的診斷測試來控制疫情。 因此，世界各國政府與研究機構和公司合作，使用這種方法來識別和診斷 SARS-CoV-2。 幾家公司已經宣布了用於監測 SARS-CoV-2 病毒的基因組服務和快速解決方案。 例如，QIAGEN 提供全基因組測序服務 SARS-CoV-2 監測，用於識別強效變異體、追蹤可能的爆發以及推進疫苗研究和藥物開發。

全基因組測序市場報告亮點

  • 消耗品部分在 2022 年佔據了最大份額，達到 61.56%，這是因為可用的消耗品種類繁多，而且由於這些產品的使用時間較短，因此採用率越來越高。。
  • 按類型劃分，大型全基因組測序細分市場在 2022 年全基因組測序市場中所佔份額最大，為 77.32%。 這可能是由於癌症腫瘤分析和罕見疾病基因突變鑑定等應用的擴展。
  • 按工作流程劃分，測序部分在 2022 年佔據了 52.12% 的最大市場份額，這是由於大公司越來越多地參與以及新產品的推出推動了該流程的採用。
  • 按應用劃分，人類全基因組測序細分市場在 2022 年以 62.91% 的份額佔據市場主導地位。 這可能是由於罕見遺傳病的流行率不斷上升，以及為查明這些疾病的病原體而進行的研發投資不斷增加。
  • 按最終用途劃分，學術和研究部門以 48.72% 的最大份額主導著全球市場。 該細分市場的很大一部分歸因於這些設施對高通量技術的需求不斷增長，以便在該領域進行綜合研究。
  • 北美在 2022 年所佔份額最大，為 51.34%。 這一巨大份額可歸因於該地區成熟的醫療保健系統和製藥業的存在，從而對用於臨床和研究目的的全基因組測序產生了巨大需求。

內容

第一章調查方法及範圍

  • 信息採購
  • 信息或數據分析
  • 市場範圍和細分定義
  • 市場模型
    • 市場調查，按公司市場份額
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場前景
  • 市場動態
    • 遺傳病患病率上升
    • 降低基因測序的成本
    • 基因組作圖項目對全基因組測序的需求不斷增長
  • 市場製約因素分析
    • 與基因組測序相關的倫理和法律問題
  • 行業分析工具
    • 波特的五力分析
    • 宏觀經濟分析
  • COVID-19 影響分析

第 4 章全基因組測序市場：產品業務分析

  • 全基因組測序市場：產品市場份額分析
  • 全基因組測序市場的估計和預測，按產品分類（百萬美元）
  • 設備
  • 消耗品
  • 服務

第 5 章全基因組測序市場：類型業務分析

  • 全基因組測序市場：類型市場份額分析
  • 全基因組測序市場按類型估算和預測（百萬美元）
  • 大規模全基因組測序
  • 小型全基因組測序

第 6 章全基因組測序市場：工作流程業務分析

  • 全基因組測序市場：工作流程市場份額分析
  • 按工作流程估算和預測全基因組測序市場（百萬美元）
  • 前序
  • 測序
  • 數據分析

第 7 章全基因組測序市場：應用業務分析

  • 全基因組測序市場：應用市場份額分析
  • 全基因組測序市場按應用估算和預測（百萬美元）
  • 人類全基因組測序
  • 全植物外顯子組測序
  • 全動物外顯子組測序
  • 微生物全外顯子組測序

第 8 章全基因組測序市場：最終用途業務分析

  • 全基因組測序市場：最終用途市場份額分析
  • 全基因組測序市場的估計和預測，按最終用途（百萬美元）
  • 學術和研究機構
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

第 9 章全基因組測序市場：區域業務分析

  • 2022 年和 2030 年各地區全基因組測序市場份額
  • 北美
    • 美國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 歐洲
    • 德國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 英國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 法國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 意大利
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 西班牙
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 丹麥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 瑞典
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 挪威
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 亞太地區
    • 日本
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 中國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 印度
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 韓國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 泰國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 拉丁美洲
    • 巴西
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 墨西哥
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿根廷
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
  • 多邊環境協定
    • 南非
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 沙特阿拉伯
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 阿拉伯聯合酋長國
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景
    • 科威特
      • 主要國家動態
      • 目標疾病的患病率
      • 競爭場景
      • 監管框架
      • 贖回場景

第10章競爭格局

  • 公司分類
  • 2022 年市場公司份額分析
  • 戰略規劃
  • 公司簡介/列表
    • Illumina, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Thermo Fisher Scientific, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Oxford Nanopore Technologies
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Pacific Biosciences of California, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • BGI
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • QIAGEN
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Agilent Technologies
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • ProPhase Labs, Inc. (Nebula Genomics)
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Psomagen
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
    • Azenta US, Inc. (GENEWIZ)
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • Product Benchmarking
      • Strategic Initiatives
Product Code: GVR-4-68040-037-0

Whole Genome Sequencing Market Growth & Trends:

The global whole genome sequencing market size is projected to reach USD 6.67 billion by 2030, expanding at a CAGR of 20.06% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising adoption of whole genome sequencing for genome mapping programs and the increasing prevalence of inherited disorders, including rare genetic disorders. According to the study published in the New England Journal of Medicine in November 2021, whole genome sequencing could lead to the early diagnosis of a wide range of rare diseases and a reported transition to precision medicine.

Furthermore, the growing investment in R&D for the early detection and treatment of disorders with the aid of WGS is expected to propel the growth of the market. For instance, in February 2023, the government of Indonesia and the Genome Science Initiative, with the aid of a USD 30 million investment from the Global Fund, established a network of facilities to perform the method for the early detection and treatment of disorders, including COVID-19, tuberculosis, cancer, genetic disorders, brain diseases, and metabolic disorders.

Whole genome sequencing has a wide range of applications, and government bodies are adopting these technologies for sequencing the genomes of humans, plant, animal, and microbes, which is expected to drive market growth. For instance, U.S. Food & Drug Administration (FDA) adopted the method to identify foodborne pathogens during foodborne disease outbreaks across the countries. The FDA has adopted this technology since 2008 under the Whole Genome Sequencing (WGS) program as it enables it to distinguish all strains of foodborne pathogens more efficiently than pulse-field gel electrophoresis (PFGE).

The rising technological advancements have led to the launch of innovative whole genome sequencing products that offer an affordable, accurate, and timely diagnosis of various diseases and infections. This is contributing to the growth of the market. For instance, in December 2022, LifeCell International Pvt. Ltd. collaborated with HaystackAnalytics to launch TB, a whole genome sequencing test to identify the diagnostic information on tuberculosis infections and tackle the drug resistance challenge.

The COVID-19 pandemic led to an increased demand for the method globally, which enabled the rapid identification of SARS-CoV-2 and the development of possible diagnostic tests to manage the outbreak. Hence, governments across the globe collaborated with research organizations and the corporate sector to use the method to identify and diagnose SARS-CoV-2. Several companies have launched genomic services and rapid solutions for the surveillance of the SARS-CoV-2 virus. For instance, QIAGEN offers the whole genome sequencing services SARS-CoV-2 surveillance for the identification of potent mutants, tracing of possible outbreaks, and advancement of vaccine research and drug development.

Whole Genome Sequencing Market Report Highlights:

  • Consumables segment held the largest share of 61.56% in 2022, owing to the availability of a wide range of consumables and increased adoption of these products due to the shorter duration of use of these products
  • By type, the large whole genome sequencing segment accounted for the largest share of 77.32% in the whole genome sequencing market in 2022. This can be attributed to the growing applications for analyzing cancerous tumors and identifying genetic variations in rare diseases
  • By workflow, the sequencing segment held the largest market share of 52.12% in 2022, owing to the growing involvement of major companies and the launch of novel products to boost the adoption of the process
  • By application, the human whole genome sequencing segment dominated the market in 2022 with a share of 62.91%. This can be attributed to the growing prevalence of rare inherited disorders and growing investment in R&D for the method to identify possible causative agents of these disorders
  • By end-use, the academic & research institutes segment dominated the global market with the largest share of 48.72%. The large share of the segment can be attributed to the growing demand for high-throughput technologies at these facilities to conduct comprehensive research in this field
  • North America held the largest market share of 51.34% in 2022. The large share can be attributed to the presence of a well-established healthcare system and pharmaceutical industry in the region, which has created a significant demand for whole genome sequencing for clinical and research purposes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Rising prevalence of inherited disorders
    • 3.3.2. Decreasing costs for genetic sequencing
    • 3.3.3. Rising demand for whole genome sequencing for genome mapping programs
  • 3.4. Market Restraint Analysis
    • 3.4.1. Ethical and legal challenges associated with genomic sequencing
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macroeconomic Analysis
  • 3.6. COVID-19 Impact Analysis

Chapter 4. Whole Genome Sequencing Market: Product Business Analysis

  • 4.1. Whole Genome Sequencing Market: Product Market Share Analysis
  • 4.2. Whole Genome Sequencing Market Estimates & Forecast, By Product (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Whole Genome Sequencing Market: Type Business Analysis

  • 5.1. Whole Genome Sequencing Market: Type Market Share Analysis
  • 5.2. Whole Genome Sequencing Market Estimates & Forecast, By Type (USD Million)
  • 5.3. Large Whole Genome Sequencing
    • 5.3.1. Large Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 5.4. Small Whole Genome Sequencing
    • 5.4.1. Small Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 6. Whole Genome Sequencing Market: Workflow Business Analysis

  • 6.1. Whole Genome Sequencing Market: Workflow Market Share Analysis
  • 6.2. Whole Genome Sequencing Market Estimates & Forecast, By Workflow (USD Million)
  • 6.3. Pre-Sequencing
    • 6.3.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
  • 6.4. Sequencing
    • 6.4.1. Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Data Analysis
    • 6.5.1. Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Whole Genome Sequencing Market: Application Business Analysis

  • 7.1. Whole Genome Sequencing Market: Application Market Share Analysis
  • 7.2. Whole Genome Sequencing Market Estimates & Forecast, By Application (USD Million)
  • 7.3. Human Whole Genome Sequencing
    • 7.3.1. Human Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.4. Plant Whole Exome Sequencing
    • 7.4.1. Plant Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.5. Animal Whole Exome Sequencing
    • 7.5.1. Animal Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
  • 7.6. Microbial Whole Exome Sequencing
    • 7.6.1. Microbial Market, 2018 - 2030 (USD Million)

Chapter 8. Whole Genome Sequencing Market: End-Use Business Analysis

  • 8.1. Whole Genome Sequencing Market: End-Use Market Share Analysis
  • 8.2. Whole Genome Sequencing Market Estimates & Forecast, By End-Use (USD Million)
  • 8.3. Academic & Research Institutes
    • 8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.4. Hospitals & Clinics
    • 8.4.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotechnology Companies
    • 8.5.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Whole Genome Sequencing Market: Regional Business Analysis

  • 9.1. Whole Genome Sequencing Market Share By Region, 2022 & 2030
  • 9.2. North America
    • 9.2.1. North America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Target Disease Prevalence
      • 9.2.2.3. Competitive Scenario
      • 9.2.2.4. Regulatory Framework
      • 9.2.2.5. Reimbursement Scenario
      • 9.2.2.6. U.S. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Prevalence
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. Canada Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.2. Germany
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Target Disease Prevalence
      • 9.3.2.3. Competitive Scenario
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. Reimbursement Scenario
      • 9.3.2.6. Germany Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.3. U.K.
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Prevalence
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. U.K. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Prevalence
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. France Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Prevalence
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. Italy Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Prevalence
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Spain Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Prevalence
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Denmark Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Prevalence
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Sweden Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Prevalence
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Norway Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Target Disease Prevalence
      • 9.4.2.3. Competitive Scenario
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. Reimbursement Scenario
      • 9.4.2.6. Japan Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Prevalence
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. China Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Prevalence
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. India Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Prevalence
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. South Korea Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Prevalence
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. Australia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Prevalence
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Thailand Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Target Disease Prevalence
      • 9.5.2.3. Competitive Scenario
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Reimbursement Scenario
      • 9.5.2.6. Brazil Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Prevalence
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Mexico Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Prevalence
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Argentina Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Target Disease Prevalence
      • 9.6.2.3. Competitive Scenario
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Reimbursement Scenario
      • 9.6.2.6. South Africa Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Prevalence
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. Saudi Arabia Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Prevalence
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. UAE Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Prevalence
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. Kuwait Whole Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Company Market Share Analysis, 2022
  • 10.3. Strategy Mapping
  • 10.4. Company Profiles/Listing
    • 10.4.1. Illumina, Inc.
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Oxford Nanopore Technologies
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Pacific Biosciences of California, Inc.
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. BGI
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. QIAGEN
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Agilent Technologies
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. ProPhase Labs, Inc. (Nebula Genomics)
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Psomagen
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Azenta US, Inc. (GENEWIZ)
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Global whole genome sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 11 North America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 12 North America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 U.S. whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 16 U.S. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 U.S. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Canada whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 21 Canada whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 22 Canada whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Canada whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Europe whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 28 Europe whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 29 Europe whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Europe whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 U.K. whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 32 U.K. whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 33 U.K. whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 34 U.K. whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 35 U.K. whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Germany whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 37 Germany whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Germany whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Germany whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 Germany whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 France whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 42 France whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 43 France whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 France whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 45 France whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Italy whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 47 Italy whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 48 Italy whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Italy whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 50 Italy whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Spain whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 52 Spain whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 53 Spain whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 Spain whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Spain whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Denmark whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 57 Denmark whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 58 Denmark whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Denmark whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 60 Denmark whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Sweden whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 62 Sweden whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 63 Sweden whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 64 Sweden whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Sweden whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Norway whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Norway whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 68 Norway whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Norway whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 70 Norway whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Japan whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 78 Japan whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 79 Japan whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Japan whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Japan whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 China whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 83 China whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 84 China whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 China whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 86 China whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 India whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 88 India whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 89 India whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 90 India whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 91 India whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Australia whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 93 Australia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 94 Australia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 Australia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 96 Australia whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 97 Thailand whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 98 Thailand whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 99 Thailand whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 100 Thailand whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 101 Thailand whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 South Korea whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 103 South Korea whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Korea whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 South Korea whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Korea whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Latin America whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 108 Latin America whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 109 Latin America whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 110 Latin America whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 111 Latin America whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 112 Latin America whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Brazil whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 114 Brazil whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 115 Brazil whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Brazil whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 117 Brazil whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 Mexico whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 119 Mexico whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 120 Mexico whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 121 Mexico whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 122 Mexico whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 123 Argentina whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 124 Argentina whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 125 Argentina whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 126 Argentina whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa whole genome sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 134 South Africa whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 135 South Africa whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 137 South Africa whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 144 UAE whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 145 UAE whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 146 UAE whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 147 UAE whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait whole genome sequencing market, by product, 2018 - 2030 (USD Million)
  • Table 150 Kuwait whole genome sequencing market, by type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait whole genome sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 152 Kuwait whole genome sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait whole genome sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products/services
  • Table 160 Key companies undergoing partnerships
  • Table 161 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Whole genome sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Whole genome sequencing - Industry value chain analysis
  • Fig. 15 Whole genome sequencing market dynamics
  • Fig. 16 Whole genome sequencing market: Porter's analysis
  • Fig. 17 Whole genome sequencing market: PESTLE analysis
  • Fig. 18 Whole genome sequencing market: Product outlook and key takeaways
  • Fig. 19 Whole genome sequencing market: Product market share analysis, 2022 - 2030
  • Fig. 20 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 21 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 22 Global services market, 2018 - 2030 (USD Million)
  • Fig. 23 Whole genome sequencing market: Type outlook and key takeaways
  • Fig. 24 Whole genome sequencing market: Type market share analysis, 2022 - 2030
  • Fig. 25 Global large whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 26 Global small whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 27 Whole genome sequencing market: Workflow outlook and key takeaways
  • Fig. 28 Whole genome sequencing market: Workflow market share analysis, 2022 - 2030
  • Fig. 29 Global pre-sequencing market, 2018 - 2030 (USD Million)
  • Fig. 30 Global sequencing market, 2018 - 2030 (USD Million)
  • Fig. 31 Global data analysis market, 2018 - 2030 (USD Million)
  • Fig. 32 Whole genome sequencing market: Application outlook and key takeaways
  • Fig. 33 Whole genome sequencing market: Application market share analysis, 2022 - 2030
  • Fig. 34 Global human whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 35 Global plant whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 36 Global animal whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 37 Global microbial whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 38 Whole genome sequencing market: End-use outlook and key takeaways
  • Fig. 39 Whole genome sequencing market: End-use market share analysis, 2022 - 2030
  • Fig. 40 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 41 Global hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 42 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 43 Global others market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. key country dynamics
  • Fig. 48 U.S. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Canada key country dynamics
  • Fig. 50 Canada whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 51 Europe whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 U.K. key country dynamics
  • Fig. 53 U.K. whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Germany key country dynamics
  • Fig. 55 Germany whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France key country dynamics
  • Fig. 57 France whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy key country dynamics
  • Fig. 59 Italy whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain key country dynamics
  • Fig. 61 Spain whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark key country dynamics
  • Fig. 63 Denmark whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden key country dynamics
  • Fig. 65 Sweden whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Norway key country dynamics
  • Fig. 67 Norway whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Asia-Pacific whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 China key country dynamics
  • Fig. 72 China whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 India key country dynamics
  • Fig. 74 India whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand key country dynamics
  • Fig. 78 Thailand whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea key country dynamics
  • Fig. 80 South Korea whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Brazil key country dynamics
  • Fig. 83 Brazil whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Mexico key country dynamics
  • Fig. 85 Mexico whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina key country dynamics
  • Fig. 87 Argentina whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 MEA whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa key country dynamics
  • Fig. 90 South Africa whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia key country dynamics
  • Fig. 92 Saudi Arabia whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 UAE key country dynamics
  • Fig. 94 UAE whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait key country dynamics
  • Fig. 96 Kuwait whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Key company categorization
  • Fig. 98 Company market positioning
  • Fig. 99 Company market share analysis, 2022
  • Fig. 100 Market participant categorization
  • Fig. 101 Strategy framework